Oxford Health NHS Foundation Trust
Oxford, Oxfordshire, OX3 7JX, United Kingdom
NCT Number: NCT06465173
This study aims to investigate whether self-compassion is associated with older adult's quality of life after a diagnosis of dementia, and whether perceived threat posed by dementia mediates this relationship. Self-compassion has been found to be positive in supporting individuals in times of difficulty, in adjustment processes and older adults' wellbeing. While different factors have begun to be identified which are associated with individuals' psychological wellbeing and adjustment following a dementia diagnosis, little is known about the influence of self-compassion.
Participants will be recruited via NHS memory clinics, Join Dementia Research and from the community via third-sector organisations. Individuals will be invited to attend a Microsoft Teams/telephone appointment in which informed consent and cognitive screening processes will take place at the start. Eligible participants will then be invited to continue to complete measures administered by a researcher and an interview question. Participants will be offered the opportunity to complete the measures in a second session (within 8 weeks) or using the online survey software, Qualtrics, if preferred.
A small pilot study (n = 5) will take place prior to the main study.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Oxford, Oxfordshire, OX3 7JX, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Through study completion, average 40-60 minutes
The Quality of Life in Alzheimer's Disease consists of 13 items relating to different aspects of quality of life, such as mood, physical health, friends and ability to do things for fun. Each item is scored from 1 ('poor') to 4 ('excellent') to calculate a total score.
Time frame: Through study completion, average 40-60 minutes
The Stress Appraisal Measure consists of 28 items pertaining to perceived future threat, measured across seven subscales; three referring to primary appraisals of threat, centrality and challenge, three relating to secondary appraisal - controllable by self, controllable by others and uncontrollable), and stressfulness. Only the threat and 'stressfulness' subscales, consisting of four items respectively, will be completed.
Time frame: Through study completion, average 40-60 minutes
The Geriatric Depression Scale - 10, consisting of 10 items relating to how the person has felt over the past week (e.g. 'do you feel happy most of the time?'), has good reliability (α = 0.75), sensitivity and specificity. The Geriatric Depression Scale -10 is considered a reliable screening measure for major depression in older adults.
Time frame: Through study completion, average 40-60 minutes
The Self-Compassion Scale - Short Form consists of 12 items relating to six subscales (self-judgement, self-kindness, common humanity, mindfulness, isolation and over-identification), with each item scored from 1 ('almost never') to 5 ('almost always') and three items reverse-scored. The Self-Compassion Scale - Short Form is a shortened version of the Self-Compassion Scale. It is recommended utilising a total mean score calculated using the subscale mean scores, and this will be adopted in the current study to form the independent variable.
Oxford Health NHS Foundation Trust
Other Gov
Is Self-compassion Associated With Older Adults' Quality of Life After Dementia Diagnosis and Does Perceived Threat Posed by Dementia Mediate This Relationship?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details